Cytokine profiling in patients with polypoidal choroidal vasculopathy before and after intravitreal injection of ranibizumab.

OBJECTIVE This study aims to investigate the cytokines profiling in the aqueous humor of patients with polypoidal choroidal vasculopathy (PCV) before and after intravitreal ranibizumab injection (IVR). METHODS 14 patients clinically diagnosed with PCV and 15 cataract patients of similar age and gender (control group) were included. Throughout the cataract surgery and IVR, aqueous humor samples were collected from the PCV and control groups. RESULTS The levels of macrophage inflammatory protein 1β (MIP-1β) and normal T cell expressed and secreted (RANTES) in PCV patients were significantly lower than control subjects (P=0.045 and P=0.004, respectively). The concentration of vascular endothelial growth factor-A (VEGF-A) was significantly higher than the control group (P=0.003). The level of MIP-1β was greatly increased in PCV patients compared to prior to IVR (P=0.001). After IVR, the level of VEGF-A in PCV patients were considerably lower compared to before IVR (P=0.001). There was no link between the expression of several cytokines (MCP-1, MIP-1, Eotaxin, G-CSF, IL-8, IL-6, IL-5, IP-10 and IFN-γ) in the aqueous humor of PCV patients before and after intravitreal ranibizumab injection (IVR). The association between IL-5 expression and central macular thickness (CMT) was discovered before IVR (P=0.02), however, the correlation between several cytokines (MCP-1, MIP-1, Eotaxin, G-CSF, IL-8, IL-6, IL-5, IP-10 and IFN-γ) was discovered in PCV patients after IVR. CONCLUSION Based on our findings, we discovered that the production of neovascularization in PCV patients is driven by both angiogenic and inflammatory factors, with a correlation seen between several cytokines.

[1]  Muna Bhende,et al.  Polypoidal choroidal vasculopathy: Pearls in diagnosis and management , 2018, Indian journal of ophthalmology.

[2]  A. Tsujikawa,et al.  Five-year visual outcomes after anti-VEGF therapy with or without photodynamic therapy for polypoidal choroidal vasculopathy , 2018, British Journal of Ophthalmology.

[3]  J. Connolly,et al.  Dataset of plasma and aqueous humor cytokine profiles in patients with exudative age related macular degeneration and polypoidal choroidal vasculopathy , 2018, Data in brief.

[4]  T. Wong,et al.  Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management. , 2018, Ophthalmology.

[5]  Y. Teo,et al.  Shared genetic variants for polypoidal choroidal vasculopathy and typical neovascular age-related macular degeneration in East Asians , 2017, Journal of Human Genetics.

[6]  C. Cheung,et al.  Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians , 2016, Progress in Retinal and Eye Research.

[7]  J. Prestegard,et al.  Interactions of the Chemokine CCL5/RANTES with Medium-Sized Chondroitin Sulfate Ligands. , 2015, Structure.

[8]  Min Zhao,et al.  Interleukin-1β Level Is Increased in Vitreous of Patients with Neovascular Age-Related Macular Degeneration (nAMD) and Polypoidal Choroidal Vasculopathy (PCV) , 2015, PloS one.

[9]  A. Luster,et al.  Chemokines and chemokine receptors: positioning cells for host defense and immunity. , 2014, Annual review of immunology.

[10]  L. Yao,et al.  Roles of the Chemokine System in Development of Obesity, Insulin Resistance, and Cardiovascular Disease , 2014, Journal of immunology research.

[11]  Takashi Baba,et al.  Associations of IL-23 with polypoidal choroidal vasculopathy. , 2012, Investigative ophthalmology & visual science.

[12]  H. Kuo,et al.  High Glucose-treated Macrophages Augment E-Selectin Expression in Endothelial Cells* , 2011, The Journal of Biological Chemistry.

[13]  F. Mach,et al.  CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke , 2010, Thrombosis and Haemostasis.

[14]  K. Clément,et al.  CCL5 Promotes Macrophage Recruitment and Survival in Human Adipose Tissue , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[15]  Wen-Chuan Wu,et al.  Polypoidal choroidal vasculopathy in Taiwanese patients. , 2009, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[16]  L. Yeung,et al.  Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results , 2009, British Journal of Ophthalmology.

[17]  M. Teixeira,et al.  Role of the chemokines CCL3/MIP-1 alpha and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice. , 2009, Microvascular research.

[18]  T. Ogihara,et al.  Macrophage inflammatory protein-1beta induced cell adhesion with increased intracellular reactive oxygen species. , 2009, Journal of molecular and cellular cardiology.

[19]  I. Maruko,et al.  Clinical characteristics of exudative age-related macular degeneration in Japanese patients. , 2007, American journal of ophthalmology.

[20]  K. Alitalo,et al.  Molecular regulation of angiogenesis and lymphangiogenesis , 2007, Nature Reviews Molecular Cell Biology.

[21]  F. Wen,et al.  Subtype lesions of neovascular age-related macular degeneration in Chinese patients , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[22]  W. Buhre,et al.  Differential and additive effects of platelet‐derived chemokines on monocyte arrest on inflamed endothelium under flow conditions , 2005, Journal of leukocyte biology.

[23]  S. Stacker,et al.  Molecular regulation of the VEGF family – inducers of angiogenesis and lymphangiogenesis , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[24]  M. Matsumura,et al.  Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy , 2004, British Journal of Ophthalmology.

[25]  M. Ratajczak,et al.  CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor. , 2002, Blood.

[26]  Y. Miyake,et al.  Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation , 2002, The British journal of ophthalmology.

[27]  B. Lafaut,et al.  Polypoidal choroidal vasculopathy in Caucasians , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.

[28]  D. S. Garrett,et al.  High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR. , 1994, Science.

[29]  G. Pagès,et al.  VEGF Splicing and the Role of VEGF Splice Variants: From Physiological-Pathological Conditions to Specific Pre-mRNA Splicing. , 2015, Methods in molecular biology.

[30]  K. Clément,et al.  CCL 5 Promotes Macrophage Recruitment and Survival in Human Adipose Tissue , 2009 .

[31]  L A Yannuzzi,et al.  IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV) , 1990, Retina.